Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
- PMID: 18796623
- DOI: 10.1182/blood-2008-02-139725
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
Abstract
Notch signaling is involved in tumorigenesis, but its role in B-chronic lymphocytic leukemia (B-CLL) pathogenesis is not completely defined. This study examined the expression and activation of Notch receptors in B-CLL cells and the role of Notch signaling in sustaining the survival of these cells. Our results show that B-CLL cells but not normal B cells constitutively express Notch1 and Notch2 proteins as well as their ligands Jagged1 and Jagged2. Notch signaling is constitutively activated in B-CLL cells, and its activation is further increased in B-CLL cells, which resist spontaneous apoptosis after 24-hour ex vivo culture. Notch stimulation by a soluble Jagged1 ligand increases B-CLL cell survival and is accompanied by increased nuclear factor-kappa B (NF-kappaB) activity and cellular inhibitor of apoptosis protein 2 (c-IAP2) and X-linked inhibitor of apoptosis protein (XIAP) expression. In contrast, Notch-signaling inhibition by the gamma-secretase inhibitor I (GSI; z-Leu-Leu-Nle-CHO) and the specific Notch2 down-regulation by small-interfering RNA accelerate spontaneous B-CLL cell apoptosis. Apoptotic activity of GSI is accompanied by reduction of NF-kappaB activity and c-IAP2 and XIAP expression. Overall, our findings show that Notch signaling plays a critical role in B-CLL cell survival and apoptosis resistance and suggest that it could be a novel potential therapeutic _target.
Comment in
-
B-CLL kicks it up a Notch.Blood. 2009 Jan 22;113(4):765-6. doi: 10.1182/blood-2008-10-182998. Blood. 2009. PMID: 19164502 No abstract available.
Similar articles
-
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.Int J Cancer. 2013 Apr 15;132(8):1940-53. doi: 10.1002/ijc.27863. Epub 2012 Oct 17. Int J Cancer. 2013. PMID: 23001755
-
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.Cell Death Dis. 2018 Nov 26;9(12):1160. doi: 10.1038/s41419-018-1185-6. Cell Death Dis. 2018. PMID: 30478302 Free PMC article.
-
Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors.EMBO J. 1999 May 17;18(10):2803-11. doi: 10.1093/emboj/18.10.2803. EMBO J. 1999. PMID: 10329626 Free PMC article.
-
Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells.Curr Mol Med. 2014 May;14(4):523-34. doi: 10.2174/1566524014666140331230411. Curr Mol Med. 2014. PMID: 24694299 Review.
-
[Notch signal pathway and chronic lymphocytic leukemia].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Oct;22(5):1472-5. doi: 10.7534/j.issn.1009-2137.2014.05.055. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 25338610 Review. Chinese.
Cited by
-
RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival.Cell Death Dis. 2016 Jul 21;7(7):e2300. doi: 10.1038/cddis.2016.213. Cell Death Dis. 2016. PMID: 27441652 Free PMC article.
-
NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro.Breast Cancer Res. 2012 Sep 19;14(5):R126. doi: 10.1186/bcr3321. Breast Cancer Res. 2012. PMID: 22992387 Free PMC article.
-
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status.Front Oncol. 2021 May 26;11:668573. doi: 10.3389/fonc.2021.668573. eCollection 2021. Front Oncol. 2021. PMID: 34123837 Free PMC article.
-
Cutaneous T-cell lymphomas: a review of new discoveries and treatments.Curr Treat Options Oncol. 2012 Mar;13(1):102-21. doi: 10.1007/s11864-011-0179-8. Curr Treat Options Oncol. 2012. PMID: 22311555 Review.
-
Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug _targets.Cells. 2018 Oct 20;7(10):176. doi: 10.3390/cells7100176. Cells. 2018. PMID: 30347849 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
